Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder

Somatic symptom disorder (SSD) is a psychiatric diagnosis featured with somatic distress and health anxiety. It is overlapped with functional disorders. Whether it has effective treatment is a clinically important issue. Current evidence indicates that pharmacotherapy and psychotherapy are both helpful for SSD. Among other treatment options, repetitive transcranial magnetic stimulation (rTMS) is attached important in psychiatric field; it can cause activation or inhibition of specific brain regions via magnetic stimulation. Previous studies have disclosed that rTMS is helpful for depression, obsessive-compulsive disorder, post-stroke rehabilitation, etc. Regarding functional disorders, fibromyalgia has been found to be benefited from rTMS; the effective approaches include giving high-frequency stimulation on left M1 and dorsolateral prefrontal cortex (DLPFC). Chronic tinnitus was also found to have response to rTMS. SSD and fibromyalgia are highly overlapped; SSD and depression are often comorbid. Therefore, SSD may also be benefited from left DLPFC high-frequency stimulation. Our previous study revealed that dysfunction of anterior cingulate cortex (ACC) is associated with persistent interference of the somatic discomforts; stimulation on DLPFC can cause ACC activation. This study program was designed based on the above information. It is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The primary outcomes are somatic distress and health anxiety. There is not study about rTMS on SSD in literature; the investigators expect this study to be able to provide more understanding on this field.

• Scores of Patient Health Questionnaire-15 (PHQ-15) [Срок оценки: Week 1, 2 (comparing with the data in week 0) of the two sections (rTMS and sham)]
• Scores of Health Anxiety Questionnaire (HAQ) [Срок оценки: Week 1, 2 (comparing with the data in week 0) of the two sections (rTMS and sham)]
• Scores of Beck Depression Inventory-II (BDI-II) [Срок оценки: Week 1, 2, 3 (comparing with the data in week 0) of the two sections (rTMS and sham)]
• Scores of Beck Anxiety Inventory (BAI) [Срок оценки: Week 1, 2, 3 (comparing with the data in week 0) of the two sections (rTMS and sham)]
• Scores of Cognitions About Body and Health Questionnaire (CABAH) [Срок оценки: Week 1, 2, 3 (comparing with the data in week 0) of the two sections (rTMS and sham)]
• Heart rate variability [Срок оценки: Week 1, 2, 3 (comparing with the data in week 0) of the two sections (rTMS and sham)]
• Skin conductance [Срок оценки: Week 1, 2, 3 (comparing with the data in week 0) of the two sections (rTMS and sham)]